Lymph Node Tuberculosis: Criteria for Cure and Optimal Duration of Treatment
Introduction: Extra-pulmonary tuberculosis has increased significantly and reached a relatively high level. Lymph node tuberculosis represents the most frequent localization and in some areas exceeds 80% of cases. The absence of healing criteria increases the therapeutic difficulties observed despite a well controlled compliance.
Methods: Our study is prospective including patients treated for lymph node tuberculosis in the tuberculosis control departments of five departments in Algeria during the year 2017 for tuberculosis. Case treatment outcomes were assessed by comparing three groups according to the duration of treatment (6, 9 and 12 months).
Results: Of the 4279 cases of tuberculosis recorded, 3327 patients were treated for extra-pulmonary tuberculosis (77.7%), including 2329 cases of lymph node tuberculosis. The sex ratio is 0.43. The personal and / or family history of tuberculosis was found in 27.4% of cases. A comorbidity including diabetes was found in 13% of cases. Cervical involvement predominates with 87.5% of cases. The association with pulmonary tuberculosis or other extra-pulmonary disease was recorded in 11%. Tuberculosis origin was proven in 67% and presumed in 33%. Healing was defined as complete disappearance or lymphadenopathy less than 15 mm. Among the 2329 patients, 1607 were declared cured at the end of the 6th month, 1647 after 9 months and 1653 cases after 12 months of treatment. The use of surgery was necessary in 11% of cases.
Conclusion: The multidisciplinary approach focused on the active participation of all specialists in ganglionic tuberculosis to improve therapeutic practices and lead to consensual behaviors.
Cite this article as: European Respiratory Journal 2018 52: Suppl. 62, PA2691.
This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).